BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Lung cancer, Liver, Autoimmunity, Phenobarbital, rs2476601, GATA1, cell-cell adhesion)
Bookmark Forward

QuickView for killed vaccines (compound)


Genetic Markers

Most Correlated Genes

  1. IGHG3
  2. CXCL8
  3. TNFRSF17
  4. IGLV1-36
  5. G0S2
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP
  2. GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP
  3. GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN
  4. GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN
  5. PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Blood from children before and after live attenuated and inactivated influenza virus vaccination
  2. Time course of young adults vaccinated against Influenza A
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.
  2. Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccin…
  3. Towards in vitro potency testing of inactivated erysipelas vaccines.
  4. Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae).
  5. Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick ce…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
  2. Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine
  3. Bridging Study for Killed Oral Cholera Vaccine in Ethiopia
  4. Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
  5. Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.